Document:

Exhibit 4.3

 

 

Board of Directors

NYSE Group, Inc.

 

March 8, 2006

 

Ladies and Gentlemen:

 

The undersigned, Executive
Vice President and Co-General Counsel of NYSE Group, Inc.,  a Delaware corporation (the “Corporation”),
is delivering this opinion in connection with the filing by the Corporation, with
the Securities and Exchange Commission of a Registration Statement on Form S-8
(the “Registration Statement”) under the Securities Act of 1933, as
amended, pursuant to which certain shares of the Corporation's common stock,
par value $.01 per share (“Shares”) are to be purchased and/or issued
under the terms of the NYSE Group, Inc. 2006 Stock Incentive Plan, the
Archipelago Holdings, L.L.C. 2000 Long-Term Incentive Plan, the Archipelago
Holdings, L.L.C. 2003 Long-Term Incentive Plan and the Archipelago Holdings
2004 Stock Incentive Plan (collectively, the “NYSE Plans”).

 

In so acting, I have
examined and relied upon the representations and warranties contained therein
or made pursuant thereto, and on certificates of officers of the Corporation
and of public officials as to factual matters, and upon the originals, or
copies certified or otherwise identified to my satisfaction, of (i) the
articles of incorporation of the Corporation, (ii) the bylaws of the
Corporation, and (iii) such other records, documents and instruments as in
my judgment are necessary or advisable to enable me to render the opinion
expressed below.

 

In all such examinations,
I have assumed the genuineness of all signatures (other than those on behalf of the Corporation), the legal capacity of natural persons, the
authenticity of all documents submitted to me as originals and the conformity
to original documents of all documents submitted to me as certified or
photostatic copies, and as to certificates and telegraphic and telephonic
confirmations given by public officials, I have assumed the same to have been
properly given and to be accurate. I have also assumed that all documents and
instruments executed by the parties to this transaction (other than those executed by representatives of the

 

 

Corporation)
have been duly and validly executed and delivered by such parties; that
the agreements entered into as part of this transaction are the legal,
valid and binding obligations of such parties, enforceable against such parties
in accordance with their terms; and that such parties have obtained all
required consents, permits and approvals required to enter into and perform such
documents and instruments.

 

Based on the foregoing
and subject to the assumptions and qualifications set forth below, I am of the opinion
that the Shares have been duly authorized for issuance and, when issued and
sold by the Corporation pursuant to and in accordance with the NYSE Plans, will
be validly issued, fully paid and nonassessable.

 

The foregoing opinions
are subject to the qualification that I do not purport to be an expert on, or
to express any opinion herein concerning, the laws of any jurisdiction other
than the General Corporation Law of the State of Delaware and New York and the
federal laws of the United States of America, and I express no opinion
concerning the securities laws of any other state.

 

I hereby consent to the
filing of this opinion with the Commission as an exhibit to the
Registration Statement. In giving this consent, I do not thereby admit that I
am in the category of persons whose consent is required under Section 7 of
the Securities Act of 1933, as amended or the rules and regulations of the
Securities and Exchange Commission promulgated thereunder.

 

This opinion letter is
limited to the matters stated, and no opinion is implied or may be
inferred beyond those opinions expressly stated herein. The opinions expressed
herein are rendered only as of the date hereof, and I assume no responsibility
to advise you of changes in law, facts, circumstances, events or developments
which hereafter may be brought to my attention and which may alter,
affect or modify such opinions. The opinions expressed herein are solely for
the benefit of the addressees of this opinion letter, and without my prior
written consent may not be relied on in any other context, quoted in whole
or in part or otherwise referred to in any legal opinion, document, or
other report, or furnished to any other person or entity.

 

	
  Sincerely,

  
	
   

  
	
   

  
	
  /s/ Richard P.
  Bernard

  	
   

  
	
   

  
	
  Richard P.
  Bernard

  
	
  Executive Vice
  President and Co-General Counsel

  
	
  NYSE Group, Inc.

  

 

2Exhibit
10.5

 

 

 

 

FIRST
AMENDMENT TO LEASE

 

FC
40 LANDSDOWNE, INC.

To

MILLENNIUM
PHARMACEUTICALS, INC.

 

40
Landsdowne Street

Cambridge,
MA

 

This First Amendment to Lease is entered into
as of the 5th day of November, 2001 between FC 40 LANDSDOWNE, INC. (“Landlord”)
and MILLENNIUM PHARMACEUTICALS, INC. (“Tenant”).

 

Reference is made to that certain lease (the “Lease”)
dated August 4, 2000 between Landlord and Tenant with respect to the land and
improvements thereon known as 40 Landsdowne Street, Cambridge, Massachusetts,
more particularly described on Exhibit B to the Lease. All capitalized terms
used herein and not otherwise defined shall have the definitions set forth in
the Lease.

 

WHEREAS, attached to the Lease as Schedule
C-4 is the Project Schedule.

 

WHEREAS, the Lease provides that Tenant has
the right, by written notice to Landlord, to advance the dates set forth in the
Project Schedule, and Tenant has in fact exercised such right.

 

WHEREAS, in Exhibit A to the Lease, the term “Annual
Fixed Rent for the Initial Term” is established as a sum of dollars per
rentable square foot, which could potentially have been adjusted in accordance
with Exhibit A-1 to the Lease, but it is now possible to establish that such
adjustment will not be appropriate.

 

WHEREAS, in Exhibit A to the Lease, a formula
for determining “Landlord’s TI Allowance,” “Landlord’s Base Systems Allowance,”
and “MEP Design Allowance” is set forth, and it is provided that the same may
be adjusted by formula set forth in Exhibit A-1 to the Lease, but it is now
possible to establish these amounts with finality (subject only to the caveat
set forth below in connection with the “Landlord’s TI Allowance”).

 

WHEREAS, the Lease provides for a “TI
Security Deposit” and “Tenant Work L/C”, as defined by formula on Exhibit A to
the Lease, and it is now possible to establish these amounts with finality.

 

WHEREAS, the Building has been granted the
benefit of that certain easement for building and overhang (the “Building and
Overhang Easement”), dated on or about the date hereof, given by MIT to
Landlord, and recorded with the local land records contemporaneously with the
recordation of the Notice of Lease pertaining to this Lease, as amended hereby,
and Tenant has been requested to make certain acknowledgements and covenants
with respect thereto.

 

 

 

WHEREAS, Landlord and Tenant have agreed to
confirm, clarify and/or modify certain provisions of the Lease.

 

NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
Landlord and Tenant agrees to modify the Lease as follows:

 

1.                                       Pursuant to
Section 2.1 of the Lease, the parties have finally determined, and hereby
confirm, that the rentable square feet of floor area of the Premises as 214,638
square feet.

 

2.                                       Exhibit A to
the Lease is hereby modified so that the applicable Basic Lease Terms set forth
therein shall the meanings set forth below:

 

	
  Annual Fixed Rent

  	
   

  	
  Lease Years One (1)
  through Five (5):

  
	
  for the Initial Term:

  	
   

  	
  $8,306,490.60.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Lease Years Six (6)
  through (11):

  
	
   

  	
   

  	
  $8,843,089.89.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Lease Years Twelve (12) through
  Seventeen (17):

  
	
   

  	
   

  	
  $9,379,865.45.

  
	
   

  	
   

  	
   

  
	
  TI Security Deposit:

  	
   

  	
  $5,646,831

  
	
   

  	
   

  	
   

  
	
  Tenant Work L/C:

  	
   

  	
  $11,291,389

  
	
   

  	
   

  	
   

  
	
  Landlord’s Base

  	
   

  	
  $11,291,389

  
	
  Systems Allowance

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Landlord’s TI:

  	
   

  	
  $10,225,650 (1)

  
	
  Allowance:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  MEP Design

  	
   

  	
  $197,696

  
	
  Allowance:

  	
   

  	
   

  

(1) It is agreed that
this amount shall be reduced by a credit, to be negotiated by Landlord and
Tenant, to account for certain costs associated with Leasehold Improvements,
that were originally contemplated to be performed by Tenant, but which are now
contemplated to be performed by Landlord, but which in any event were
contemplated to be paid for out of “Landlord’s TI Allowance.”

 

3.                                       Schedule C-4 to
the Work Letter is hereby deleted in its entirety and replaced with Schedule
C-4 attached hereto.

 

4.                                       Tenant
acknowledges and agrees that the Land is benefited by the Building and Overhang
Easement, that such Building and Overhang Easement contains certain covenants
binding upon Landlord as more particularly set forth in paragraph 3 thereof,
and that Tenant covenants and agrees that the aforesaid covenants shall
hereinafter be binding upon Tenant and anyone claiming by, through and under
Tenant.

 

 

 

 

2

 

Except as modified hereby, the Lease is
hereby ratified and confirmed in all respects.

 

	
   

  	
   

  	
  LANDLORD:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  FC 40 LANDSDOWNE, INC.

  

 

 

	
   

  	
  By: 

  	
  /s/ GAYLE B. FARRIS

  	
   

  
	
   

  	
   

  	
  Gayle B. Farris

  	
   

  
	
   

  	
   

  	
  Vice President

  	
   

  

 

 

	
   

  	
   

  	
  TENANT:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  MILLENNIUM
  PHARMACEUTICALS, INC.

  

 

 

	
   

  	
  By: 

  	
  /s/ KEVIN STARR

  	
   

  
	
   

  	
   

  	
  Kevin Starr

  	
   

  
	
   

  	
   

  	
  Chief Financial Officer

  	
   

  

 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]